News

As per the terms of the agreement, Nuokang is expected to get license to register, market and distribute Dianatal Obstetric Gel in Mainland China, Hong Kong, Macao and

As per the terms of the agreement, JHP is expected to take up the responsibility for manufacturing and supply of a proprietary ophthalmic product, which is targeted for

Under the terms of the agreement, X-Chem is expected to get an upfront and research payments, success-based discovery milestones, and technology access fees from Roche. Roche is expected

The alliance between Servier and Galapagos builds on novel OA drug targets discovered by Galapagos through its proprietary platform. Galapagos is expected to take up the responsibility of

Afinitor is approved for the treatment of patients with advanced renal cell carcinoma (RCC) whose disease has progressed on or after treatment with vascular endothelial growth factor (VEGF)-targeted

The arrangement, which is effective as of the July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with

Sapacitabine is an oral nucleoside analog prodrug that acts through a dual mechanism. The compound interferes with DNA synthesis by causing single-strand DNA breaks and induces arrest of

TH-302 is a proprietary tumor selective Hypoxia-Activated Prodrug (HAP) that specifically targets tumor hypoxia. Threshold Pharma is expected to enroll approximately 165 patients with previously untreated, locally advanced,

Evotec said that the advancement of EVT 101 into Phase II study is a part of an alliance between Evotec and Roche. Under this alliance Evotec is responsible